Bayer AG engages in the business of life science fields of healthcare and nutrition. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 92,815 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.
Follow-Up Questions
What is the price performance of BAYRY stock?
The current price of BAYRY is $7.75, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Bayer AG?
Bayer AG belongs to Pharmaceuticals industry and the sector is Health Care
What is Bayer AG market cap?
Bayer AG's current market cap is $30.4B
Is Bayer AG a buy, sell, or hold?
According to wall street analysts, 25 analysts have made analyst ratings for Bayer AG, including 5 strong buy, 7 buy, 15 hold, 1 sell, and 5 strong sell
